Evaluating the efficacy of upadacitinib in patients with moderate rheumatoid arthritis: a post-hoc analysis of the SELECT phase 3 trialsPhilip G. Conaghan, Christopher J Edwards, Song‐Chou Hsieh et al.|Rheumatology Advances in Practice|2022Cited by 5